Completing data — refresh the page later to see the latest
101961-60-8C=C(N=[N+]([O-])CC(C)C)C(=O)ODTXMRELKPKEPSO-UHFFFAOYSA-NValanimycin is an azoxy compound that is acrylic acid in which the olefinic hydrogen at position 2 has been replaced by an isobutyl-ONN-azoxy group. It has a role as an antimicrobial agent and a bacterial metabolite. It is an azoxy compound and an alpha,beta-unsaturated monocarboxylic acid. It is functionally related to an acrylic acid.
101961-60-8DTXSID701204222CHEMBL4782825CHEBI:133621UsesValanimycin is an antibiotic, which inhibits Escherichia coli (BE1121) through interaction with DNA. Valanimycin exhibits cytotoxicity to mouse leukemia L1210, P388/S (doxorubicin (HY-15142A)-sensitive), and P388/ADR (doxorubicin-resistant), with IC50 of 0.79, 2.65, and 1.44 μg/mL, respectively. Valanimycin exhibits antitumor efficacy against ehrlich ascites tumors or L1210 in mice[1].
DefinitionChEBI: Valanimycin is an azoxy compound that is acrylic acid in which the olefinic hydrogen at position 2 has been replaced by an isobutyl-ONN-azoxy group. It has a role as a bacterial metabolite and an antimicrobial agent. It is an azoxy compound and an alpha,beta-unsaturated monocarboxylic acid. It is functionally related to an acrylic acid.